Solitary Synchronous Pancreatic Metastasis from Esophageal Squamous Cell Carcinoma: A Rare Case Report

IF 0.4 Q4 ONCOLOGY

Middle East Journal of Cancer Pub Date : 2020-10-19 DOI:10.30476/MEJC.2020.86963.1379

Shahram Ahmadi Somaghian, Sepideh Mirzaei, A. Aaliehpour, Yahya Baharvand Iran Nia

{"title":"Solitary Synchronous Pancreatic Metastasis from Esophageal Squamous Cell Carcinoma: A Rare Case Report","authors":"Shahram Ahmadi Somaghian, Sepideh Mirzaei, A. Aaliehpour, Yahya Baharvand Iran Nia","doi":"10.30476/MEJC.2020.86963.1379","DOIUrl":null,"url":null,"abstract":"Pancreas is an organ that is hardly affected by metastasis from other primary cancers; also, pancreatic metastasis from esophageal squamous cell carcinoma (ESCC) is an extremely infrequent entity. Metastatic esophageal cancer has a poor prognosis and the five-year survival rate is less than 5%. Here, we described a rare case of a 78-year-old woman presented with abdominal bloating, intermittent mild nausea, and loss of appetite and weight. Esophagogastroduodenoscopy revealed ESCC in the upper part of esophagus. A mass lesion between the head and body of pancreas was detected during metastatic workup. Endoscopic ultrasound-guided fine needle aspiration was performed, morphologic features and immunohistochemistry confirmed metastatic SCC from esophagus. Definitive chemo-radiotherapy with curative intent was done on both oesophageal and pancreatic lesion. Interestingly, after nine months of treatment, the patient had no issues either in esophagus or in abdomen. In conclusion, local therapy could be considered as one of the best choices to improve the overall survival in ESCC with single metastasis to pancreas.","PeriodicalId":44005,"journal":{"name":"Middle East Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2020-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Middle East Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30476/MEJC.2020.86963.1379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Pancreas is an organ that is hardly affected by metastasis from other primary cancers; also, pancreatic metastasis from esophageal squamous cell carcinoma (ESCC) is an extremely infrequent entity. Metastatic esophageal cancer has a poor prognosis and the five-year survival rate is less than 5%. Here, we described a rare case of a 78-year-old woman presented with abdominal bloating, intermittent mild nausea, and loss of appetite and weight. Esophagogastroduodenoscopy revealed ESCC in the upper part of esophagus. A mass lesion between the head and body of pancreas was detected during metastatic workup. Endoscopic ultrasound-guided fine needle aspiration was performed, morphologic features and immunohistochemistry confirmed metastatic SCC from esophagus. Definitive chemo-radiotherapy with curative intent was done on both oesophageal and pancreatic lesion. Interestingly, after nine months of treatment, the patient had no issues either in esophagus or in abdomen. In conclusion, local therapy could be considered as one of the best choices to improve the overall survival in ESCC with single metastasis to pancreas.

查看原文本刊更多论文

食管鳞状细胞癌单发同步胰腺转移一例报道

胰腺是一个几乎不受其他原发肿瘤转移影响的器官;此外，食管鳞状细胞癌(ESCC)的胰腺转移是一个极其罕见的实体。转移性食管癌预后差，5年生存率低于5%。在这里，我们描述了一个罕见的病例，78岁的女性表现为腹胀，间歇性轻度恶心，食欲不振和体重下降。食管胃十二指肠镜示食管上部ESCC。在转移性检查中发现胰腺头部和身体之间的肿块病变。超声内镜引导下进行细针穿刺，形态学和免疫组织化学证实食管转移性鳞状细胞癌。食道及胰腺病变均行明确的化疗治疗。有趣的是，经过9个月的治疗，患者的食道和腹部都没有问题。综上所述，局部治疗可被认为是提高ESCC单发胰腺转移患者总生存率的最佳选择之一。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Middle East Journal of Cancer ONCOLOGY-

CiteScore

0.80

自引率

0.00%

发文量

审稿时长

12 weeks

期刊介绍： Middle East Journal of Cancer (MEJC) is an international peer-reviewed journal which aims to publish high-quality basic science and clinical research in the field of cancer. This journal will also reflect the current status of research as well as diagnostic and treatment practices in the field of cancer in the Middle East, where cancer is becoming a growing health problem. Lastly, MEJC would like to become a model for regional journals with an international outlook. Accordingly, manuscripts from authors anywhere in the world will be considered for publication. MEJC will be published on a quarterly basis.